These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33564254)

  • 1. The One21 Technique: An Individualized Treatment for Glabellar Lines Based on Clinical and Anatomical Landmarks.
    de Sanctis Pecora C; Pinheiro MVB; Ventura Ferreira K; Jacobino de Barros Nunes G; Miot HA
    Clin Cosmet Investig Dermatol; 2021; 14():97-105. PubMed ID: 33564254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IncobotulinumtoxinA for the Treatment of Glabella and Forehead Dynamic Lines: A Real-Life Longitudinal Case Series.
    da Cunha ALG; Vasconcelos R; Di Sessa D; Sampaio G; Ramalhoto P; Zampieri BF; Deus BS; Vasconcelos S; Bellote T; Carvalho J; Petrone G; Figueredo V; Limongi Moreira G
    Clin Cosmet Investig Dermatol; 2023; 16():697-704. PubMed ID: 36987400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the Efficacy and Durability of IncobotulinumtoxinA in the Treatment of the Upper Face in Adult Women.
    de Almeida AT; de Sanctis Pecora C; Marques ER; Contin L; de Almeida CT; da Cunha AL
    Dermatol Ther (Heidelb); 2024 Aug; 14(8):2093-2108. PubMed ID: 38954382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aesthetic ONE21 Technique for Injecting IncobotulinumtoxinA into the Forehead: Initial Experience With 86 Patients.
    de Sanctis Pecora C; Bussamara Pinheiro MV; Figueiredo V; Guerra R
    J Drugs Dermatol; 2021 Jan; 20(1):31-37. PubMed ID: 33400422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ONE21 technique for an individualized assessment and treatment of upper face wrinkles in five pairs of identical twins with IncobotulinumtoxinA.
    de Sanctis Pecora C; Ventura Ferreira K; Amante Miot H
    J Cosmet Dermatol; 2022 May; 21(5):1940-1947. PubMed ID: 35201665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomical Injection Guidelines for Glabellar Frown Lines Based on Ultrasonographic Evaluation.
    Kim SB; Kim HM; Ahn H; Choi YJ; Hu KS; Oh W; Kim HJ
    Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
    Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
    Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An observational study on glabellar wrinkle patterns in Indians.
    Kamat A; Quadros T
    Indian J Dermatol Venereol Leprol; 2019; 85(2):182-189. PubMed ID: 29620040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of efficacy data from four phase III studies of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.
    Baumann L; Brandt FS; Kane MA; Donofrio LM
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S57-65. PubMed ID: 19945006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on glabellar wrinkle patterns in Koreans.
    Kim HS; Kim C; Cho H; Hwang JY; Kim YS
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1332-9. PubMed ID: 24168325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Corrugator Supercilii and Procerus Myectomy With Endoscopic Browlift Outcomes.
    Starkman SJ; Sherris DA
    JAMA Facial Plast Surg; 2019 Sep; 21(5):375-380. PubMed ID: 31046060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Lateral Periorbital Lines with Different Dilutions of IncobotulinumtoxinA.
    Muti GF; Basso M
    J Clin Aesthet Dermatol; 2017 Sep; 10(9):27-29. PubMed ID: 29344324
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of Glabellar Injection Technique With DaxibotulinumtoxinA for Injection on Brow Position.
    Bertucci V; Green JB; Fezza JP; Brown J; Gallagher CJ; Solish N
    Aesthet Surg J; 2023 Nov; 43(Suppl 1):S10-S18. PubMed ID: 36322141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One21: A Novel, Customizable Injection Protocol for Treatment of the Forehead with IncobotulinumtoxinA.
    de Sanctis Pecora C
    Clin Cosmet Investig Dermatol; 2020; 13():127-136. PubMed ID: 32104039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines.
    Prager W; Rappl T
    J Cosmet Dermatol; 2012 Dec; 11(4):267-71. PubMed ID: 23174049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection.
    Pribitkin EA; Greco TM; Goode RL; Keane WM
    Arch Otolaryngol Head Neck Surg; 1997 Mar; 123(3):321-6. PubMed ID: 9076240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective and randomized study comparing ultrasound-guided real time injection to conventional blind injection of botulinum neurotoxin for glabellar wrinkles.
    Wu Y; Zhang Y; Li H; Lin J; Ye H; Chen X; Tang K
    J Cosmet Dermatol; 2024 Sep; 23(9):2867-2875. PubMed ID: 38726847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the Effect of Incobotulinumtoxin A for Glabellar, Forehead, and Crow's Feet Lines Using A High Dilution.
    Barbarino SC; van Loghem JAJ; Burgess CM; Corduff N
    J Clin Aesthet Dermatol; 2021 Aug; 14(8):34-40. PubMed ID: 34840655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial.
    Dubina M; Tung R; Bolotin D; Mahoney AM; Tayebi B; Sato M; Mulinari-Brenner F; Jones T; West DP; Poon E; Nodzenski M; Alam M
    J Cosmet Dermatol; 2013 Dec; 12(4):261-6. PubMed ID: 24305424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the safety and efficacy of a biosimilar abobotulinum toxin type A in treating moderate-to-severe glabellar lines: A non-inferiority double blinded randomized controlled trial.
    Afshani SM; Samadi A; Ayatollahi A; Kashani MN; Ahmad Nasdrollahi S; Hosseini H; Rezagholi Z; Hedayatjoo B; Hazegh Fetratjoo D; Ghobadi MA; Anari A; Saeedifar S; Firooz A
    J Cosmet Dermatol; 2022 Jun; 21(6):2398-2406. PubMed ID: 35340107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.